Impedimed LimitedASX: IPD

Update on Options

Sep 23, 2026 at 6:24 PM EDT · Issued by ImpediMed Limited via ASX

Filed with ASX · Sep 23, 2026 at 6:24 PM EDT

Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29 Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call

Page | 1 ImpediMed Limited Suite 31C, 12-18 Tryon Rd Lindfield NSW 2070 Australia E: investorrelations@impedimed.com W: impedimed.com 24 September 2026 Companies Announcements Office Australian Securities Exchange Update on Options ImpediMed Limited (ASX: IPD) (ImpediMed or the Company)...

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Earlier from Impedimed

Date of 2026 Annual General MeetingSep 10
Appendix 4G and Corporate Governance StatementAug 26
2026 Annual ReportAug 26
Appendix 4EAug 26
FDA Clearance for Sarcopenia Risk Assessment ReceivedAug 18

Later from Impedimed

Change of Director's Interest Notice - Mr Erik AndersonSep 29
Notice of Initial Substantial HolderOct 1
Application for quotation of securities - IPDOct 13
Notice of Annual General Meeting & Voting FormOct 14
Annual General Meeting - Online Meeting GuideOct 14

All Impedimed news releases

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed